Pages that link to "Q52558493"
Jump to navigation
Jump to search
The following pages link to The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. (Q52558493):
Displaying 50 items.
- Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women (Q24652671) (← links)
- Vitamin d status in thalassemia major: an update (Q26853149) (← links)
- Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease (Q27022366) (← links)
- Vitamin D therapy. (Q30369001) (← links)
- Relation of body fat indexes to vitamin D status and deficiency among obese adolescents (Q33488449) (← links)
- Vitamin d status and spine surgery outcomes (Q33710415) (← links)
- Derangements in bone mineral parameters and bone mineral density in south Indian subjects on antiepileptic medications (Q34169824) (← links)
- Establishing reference intervals for bone turnover markers in healthy postmenopausal women in a nonfasting state (Q34171858) (← links)
- Short communication: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users (Q34213832) (← links)
- Increase in the serum parathyroid hormone level during a bisphosphonate drug holiday (Q34219208) (← links)
- Estimation of magnesium in patients with functional hypoparathyroidism (Q34319687) (← links)
- Hypovitaminosis D in obese and overweight schoolchildren (Q34423022) (← links)
- Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency (Q34510792) (← links)
- Systemic consequences of bariatric surgery and its repercussions on oral health (Q34587870) (← links)
- Relationship between vitamin D, parathyroid hormone, and bone health. (Q34617144) (← links)
- Vitamin d deficiency in postmenopausal women - biological correlates (Q35048421) (← links)
- There is no lower threshold level for parathyroid hormone as 25-hydroxyvitamin D concentrations increase (Q36124054) (← links)
- Treatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial (Q36124085) (← links)
- Endocrine regulation of bone turnover in men. (Q36338679) (← links)
- Optimal vitamin D status and serum parathyroid hormone concentrations in African American women (Q36588840) (← links)
- Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links (Q36648170) (← links)
- Vitamin D replacement for cirrhosis-related bone disease (Q36666317) (← links)
- Serum 25-OHD insufficiency as a risk factor for hip fracture (Q36796942) (← links)
- Vitamin D insufficiency: disease or no disease? (Q36951917) (← links)
- Effects of weight loss on bone status after bariatric surgery: association between adipokines and bone markers (Q37029952) (← links)
- 25-Hydroxyvitamin D and Parathyroid Hormone Levels Are Independently Associated with the Hemoglobin A1c Level of Korean Type 2 Diabetic Patients: The Dong-Gu Study (Q37056194) (← links)
- Correlation of vitamin D, bone mineral density and parathyroid hormone levels in adults with low bone density (Q37100526) (← links)
- Influence of Vitamin D and Parathyroid Hormone on Bone and Metabolic Risk in Women with Previous Gestational Diabetes (Q37180470) (← links)
- Hypovitaminosis D in the elderly: from bone to brain (Q37189370) (← links)
- Vitamin D and aging (Q37195168) (← links)
- A cross-sectional association between bone mineral density and parathyroid hormone and other biomarkers in community-dwelling young adults: the CARDIA study (Q37215495) (← links)
- Genetically Low Vitamin D Levels, Bone Mineral Density, and Bone Metabolism Markers: a Mendelian Randomisation Study (Q37254219) (← links)
- 25-Hydroxyvitamin D in Patients With Cognitive Decline-Reply (Q37258959) (← links)
- Validation Protocol of Vitamin D Supplementation in Patients with HIV-Infection. (Q37267250) (← links)
- Vitamin D and musculoskeletal health (Q37293144) (← links)
- Vitamin D supplementation in older people (VDOP): Study protocol for a randomised controlled intervention trial with monthly oral dosing with 12,000 IU, 24,000 IU or 48,000 IU of vitamin D₃. (Q37359637) (← links)
- Analytical considerations for the biochemical assessment of vitamin D status (Q37722771) (← links)
- A spectrum of clinical presentations in seven Japanese patients with vitamin d deficiency (Q37732825) (← links)
- Changes in bone mineral parameters, vitamin D metabolites, and PTH measurements with varying chronic kidney disease stages (Q37762487) (← links)
- Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: a consensus advice from an Austrian working group (Q38034435) (← links)
- Prevention and treatment of vitamin D deficiency. (Q38057694) (← links)
- Vitamin D and bone health outcomes in older age. (Q38135885) (← links)
- Vitamin D and the athlete: emerging insights (Q38240651) (← links)
- Vitamin D status and response to Vitamin D(3) in obese vs. non-obese African American children (Q38294172) (← links)
- Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism (Q38973077) (← links)
- Prevalence of vitamin D depletion among subjects seeking advice on osteoporosis: a five-year cross-sectional study with public health implications (Q39813896) (← links)
- Vitamin D status and parathyroid hormone levels in relation to bone mineral density in apparently healthy Syrian adults (Q40776968) (← links)
- Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D₃ load in Japanese subjects (Q42664907) (← links)
- Erythrina variegata extract exerts osteoprotective effects by suppression of the process of bone resorption (Q43058335) (← links)
- Women with insufficient 25-hydroxyvitamin D without secondary hyperparathyroidism have altered bone turnover and greater incidence of vertebral fractures (Q43756654) (← links)